НОСТЕРОИД ЯЛЛИҒЛАНИШГА ҚАРШИ ПРЕПАРАТЛАРНИ ТАВСИЯ ҚИЛИШДА САЛБИЙ ДОРИ РЕАКЦИЯЛАРИНИНГ ТИББИЙ ВА ГЕНЕТИК ХУСУСИЯТЛАРИ
##article.subject##:
МДР1 геном, CYP2C19, ситохром Р-450 ферментлари, НСЯКДлар##article.abstract##
Ҳозирги босқичда тиббиёт тўхтамайди, унинг ривожланиши методологик ёндашувларни конкретлаштиришга олиб келади. Ҳозирги кунда фармакология фани тўхтаб қолмаяпти, янги дори воситалари (дори воситалари) пайдо бўлмоқда ва уларнинг сони ортиб бормоқда, улардан фойдаланишга ёндашувлар мураккаблашмоқда. Ҳозирги кунда ишлаб чиқилган дорилар тор йўналишга эга, яъни. улар ўзига хосдир. Фармакокинетикаси жараёнлари генетик жиҳатдан назорат қилинишини ҳамма билади ва дорилар асосан организм томонидан ксенобиотиклар сифатида қабул қилинади. Бу иш долзарбдир ва бугунги кунда чуқур ўрганишни талаб қилади.
Библиографические ссылки
Alekseev V. V. Modern ideas and basic principles of pain therapy // Russian Medical Journal.- 2011.- No. 1.- Special issue.- pp. 6-11.
Bikkinina, G. M. Undesirable drug reactions of nonsteroidal anti-inflammatory drugs / G. M. Bikkinina, A. R. Safuanov. - Text : direct // Young scientist. — 2015. — № 7 (87). — Pp. 269-272.— URL: https://moluch.ru/archive/87/16884
Zhuravleva M.V., Kukes V.G., Prokofiev A.B., Serebrova S.Yu., Gorodetskaya G.I., Berdnikova N.G. Rational use of NSAIDs - balance of effectiveness and safety (literature review) // International Journal of Applied and Fundamental Research. - 2016. - № 6-4. - pp. 687-696
4. Klaritskaya I.L., Rabodyagova Yu.S. Polymorphism of the CYP2C19 gene and the clinical significance of its determination. Crimean Therapeutic Journal 2013;1:19-25.
Kukes V.G., Grachev S.V., Sychev D.A., Ramenskaya G.V. Drug metabolism: scientific foundations of personalized medicine. M.- GEOTAR-Media, 2008. 304 p.
Tashenova A.I. Glycoprotein-P transport system and pharmacokinetics of drugs. Biomedicine. 2010; 4: 24–32.
Yakusheva E.N., Chernykh I.V., Shchulkin A.V., Popova N.M. Glycoprotein - P: structure, physiological role and molecular mechanisms of functional activity modulation. Successes of physiological sciences. 2014; 45 (4): 90–98.
Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: metaanalyses of individual participant data from randomised trials. Lancet. 2013 Aug 31;382 (9894):769–79. DOI: 10.1016/S0140–6736(13)60900–9. Epub 2013 May 30
Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013 Jun 1;87 (11):766–72. 11.
Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15 Suppl 3:S2. DOI: 10.1186/ar4174. Epub 2013 Jul 24. 12.
Li Y.H., Wang Y.H., Li Y, Yang L. MDR1 gene polymorphisms and clinical relevance//Yi Chuan Xue Bao. 2006, Feb. Vol.33, №2. P. 93104.
Preissner SC, Hoffmann MF, Preissner R Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy // PLoS One 2013;8(12): e82562.
Yiannakopoulou E. Pharmacogenomics of ace-tylsalicylic acid and other nonsteroidal antiinflammatory agents: clinical implications. Eur J Clin Pharmacol. 2013; 69: 1369-73.
